BRIEF-Protagonist Therapeutics Posts Q4 Loss Per Share Of $0.48
BRIEF-Protagonist Therapeutics Posts Q4 Loss Per Share Of $0.48
简介-主角治疗公司公布第四季度每股亏损0.48美元
March 10 (Reuters) - Protagonist Therapeutics Inc :
* PROTAGONIST THERAPEUTICS REPORTS FOURTH QUARTER AND FULL YEAR 2020 FINANCIAL RESULTS AND CORPORATE UPDATE
* Q4 LOSS PER SHARE $0.48
* Q4 EARNINGS PER SHARE ESTIMATE $-0.48 -- REFINITIV IBES DATA
* CASH POSITION TO FUND PLANNED OPERATIONS THROUGH FIRST HALF OF 2024
Source text for Eikon: Further company coverage:
((Reuters.Briefs@thomsonreuters.com;)
* PROTAGONIST THERAPEUTICS REPORTS FOURTH QUARTER AND FULL YEAR 2020 FINANCIAL RESULTS AND CORPORATE UPDATE
* Q4 LOSS PER SHARE $0.48
* Q4 EARNINGS PER SHARE ESTIMATE $-0.48 -- REFINITIV IBES DATA
* CASH POSITION TO FUND PLANNED OPERATIONS THROUGH FIRST HALF OF 2024
Source text for Eikon: Further company coverage:
((Reuters.Briefs@thomsonreuters.com;)
March 10 (Reuters) - Protagonist Therapeutics Inc :
* PROTAGONIST THERAPEUTICS REPORTS FOURTH QUARTER AND FULL YEAR 2020 FINANCIAL RESULTS AND CORPORATE UPDATE
* Q4 LOSS PER SHARE $0.48
* Q4 EARNINGS PER SHARE ESTIMATE $-0.48 -- REFINITIV IBES DATA
* CASH POSITION TO FUND PLANNED OPERATIONS THROUGH FIRST HALF OF 2024
Source text for Eikon: Further company coverage:
((Reuters.Briefs@thomsonreuters.com;)
路透3月10日电-主角治疗公司：*Prodicant Treeutics报告2020年第四季度和全年财务业绩和公司最新情况*第四季度每股亏损0.48美元*第四季度每股收益预估-0.48美元-REFINITIV IBES数据*现金状况，为2024年上半年之前的计划运营提供资金Eikon的源文本：进一步的公司报道：(Reurs.Briefs@thomsonreurs.com；)
译文内容由第三方软件翻译。
以上内容仅用作资讯或教育之目的，不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。
风险及免责提示
以上内容仅用作资讯或教育之目的，不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。
知道了
风险及免责提示
以上内容仅用作资讯或教育之目的，不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。
知道了
抢沙发
0 0 0
赞大爱笑哭社会社会Emm心碎怒
轻触选择心情
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能，分享给你的好友吧
点击这里分享给好友
暂无评论，快来抢沙发吧！